Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S O'Donnell

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Blood Advances|April 14, 2026
Monovalent antibody treatment of von Willebrand diseaseJames S O'Donnell
Blood Advances|July 15, 2020
Low VWF: insights into pathogenesis, diagnosis, and clinical managementJames S O'Donnell
Blood|November 20, 2025
Nanobody treatment of von Willebrand diseaseJames S O'Donnell
Seminars in Thrombosis and Hemostasis|February 26, 2021
Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand DiseaseJames S O'Donnell
Blood|December 23, 2018
How I treat low von Willebrand factor levelsMichelle Lavin, James S O'Donnell
Journal of Thrombosis and Haemostasis : JTH|January 18, 2019
Novel therapies for hemophilia A - the role of the von Willebrand factor chaperoneSonia Aguila, James S O'Donnell
Hematology. American Society of Hematology. Education Program|December 7, 2019
Perioperative management of patients with von Willebrand diseaseJames S O'Donnell, Michelle Lavin
Arteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2017
Targeting von Willebrand Factor-Mediated InflammationClive Drakeford, James S O'Donnell
Hematology. American Society of Hematology. Education Program|December 4, 2016
New treatment approaches to von Willebrand diseaseMichelle Lavin, James S O'Donnell
Thrombosis Research|October 29, 2011
Elevated plasma factor VIII levels in patients with venous thrombosis--constitutional risk factor or secondary epiphenomenon?Kevin Ryan, James S O'Donnell
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Blood Advances|April 14, 2026
Monovalent antibody treatment of von Willebrand diseaseJames S O'Donnell
Blood Advances|July 15, 2020
Low VWF: insights into pathogenesis, diagnosis, and clinical managementJames S O'Donnell
Blood|November 20, 2025
Nanobody treatment of von Willebrand diseaseJames S O'Donnell
Seminars in Thrombosis and Hemostasis|February 26, 2021
Toward Personalized Treatment for Patients with Low von Willebrand Factor and Quantitative von Willebrand DiseaseJames S O'Donnell
Blood|December 23, 2018
How I treat low von Willebrand factor levelsMichelle Lavin, James S O'Donnell
Journal of Thrombosis and Haemostasis : JTH|January 18, 2019
Novel therapies for hemophilia A - the role of the von Willebrand factor chaperoneSonia Aguila, James S O'Donnell
Hematology. American Society of Hematology. Education Program|December 7, 2019
Perioperative management of patients with von Willebrand diseaseJames S O'Donnell, Michelle Lavin
Arteriosclerosis, Thrombosis, and Vascular Biology|August 25, 2017
Targeting von Willebrand Factor-Mediated InflammationClive Drakeford, James S O'Donnell
Hematology. American Society of Hematology. Education Program|December 4, 2016
New treatment approaches to von Willebrand diseaseMichelle Lavin, James S O'Donnell
Thrombosis Research|October 29, 2011
Elevated plasma factor VIII levels in patients with venous thrombosis--constitutional risk factor or secondary epiphenomenon?Kevin Ryan, James S O'Donnell
Pageof 17